Heather B Neuman, MD, MS, FACS
- Division of Surgical Oncology
- Breast Center: (608) 266-6400
- Administrative Assistant: (608) 262-2025
600 Highland Avenue
Box 7375, Clinical Science Center
Madison, WI 53792
- MD, University of Pittsburgh School of Medicine, Pittsburgh, PA, 2000
- Surgical Oncology Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY, 2007-2009
- Residency in General Surgery, University of North Carolina, Chapel Hill, NC, 2000-2005
- National Research Service Award Fellow, Agency for Healthcare Research and Quality, Weill Medical College of Cornell University, New York, NY, 2005-2007
- Research Fellow in Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, 2005-2007
- MS, Weill Graduate School in Medical Sciences of Cornell University, New York, NY, 2007
Dr. Neuman specializes in surgical oncology with a focus on breast, melanoma and sarcoma. She is certified by the American Board of Surgery.
Dr. Neuman provides a wide range of services including Axillary Lymph Node Dissection, Core Needle Biopsy, Lumpectomy or Partial Mastectomy, Lymph Node Dissection, Melanoma Completion Lymph Node Dissection (Axillary and Groin), Melanoma Sentinel Lymph Node Biopsy, Melanoma Wide Local Excision and Skin Closure, Modified Radical Mastectomy, Needle-localized Biopsy, Needle-localized Excision, Radical Resection Soft Tissue Tumor, Sarcoma Removal of Retroperitoneal/intraabdominal Soft Tissue Tumors (Sarcomas), Sentinel Lymph Node Biopsy, Simple Mastectomy, Skin-sparing and/or Nipple-sparing Mastectomy, Wide Local Excision Skin With Reconstruction.
Dr. Neuman’s research focuses on patient-oriented clinical outcomes including patient decision-making, quality of life and survivorship. Her primary research uses mixed methods to improve the quality and efficiency of breast cancer follow-up provided to breast cancer survivors. Secondary research interests include the use of decision aids to improve patient decision-making surrounding breast cancer surgery. Additionally, she is the principal investigator for a number of surgical clinical trials focused on melanoma.
The influence of anatomic stage and receptor status on first recurrence for breast cancer within 5 years (AFT-01).
Neuman HB, Schumacher JR, Edge SB, Ruddy KJ, Partridge AH, Yu M, Vanness DJ, Hanlon BM, Le-Rademacher JG, Yang DY, Havlena J, Strand CA, Greenberg CC
Cancer 2023 Mar 06;
[PubMed ID: 36872873]
Reexamining Time From Breast Cancer Diagnosis to Primary Breast Surgery.
Wiener AA, Hanlon BM, Schumacher JR, Vande Walle KA, Wilke LG, Neuman HB
JAMA Surg 2023 Mar 01;
[PubMed ID: 36857045]
Improving patient-centered communication in breast cancer: a study protocol for a multilevel intervention of a shared treatment deliberation system (SharES) within the NCI community oncology research program (NCORP) (Alliance A231901CD).
Hawley ST, Kidwell K, Zahrieh D, McCarthy A, Wills R, Rankin A, Hofer T, Chow S, Jagsi R, Neuman H
Trials 2023 Jan 06; 24(1): 16
[PubMed ID: 36609349]
Local/regional Recurrence Rates after Breast Conserving Therapy in Patients Enrolled in Legacy Trials of the Alliance for Clinical Trials in Oncology (AFT-01).
Schumacher JR, Wiener AA, Greenberg CC, Hanlon B, Edge SB, Ruddy KJ, Partridge AH, Le-Rademacher JG, Yu M, Vanness DJ, Yang DY, Havlena J, Strand C, Neuman HB
Ann Surg 2022 Dec 14;
[PubMed ID: 36521077]
Incidence of radiation-associated sarcoma after breast-conserving surgery plus radiation.
Wiener AA, Schumacher JR, Hanlon B, Anderson B, Neuman HB
J Surg Oncol 2023 Mar; 127(4): 535-540
[PubMed ID: 36477419]